Low‐Dose NIR‐II Preclinical Bioimaging Using Liposome‐Encapsulated Cyanine Dyes
Small · 2023
DOI: 10.1002/smll.202206544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Duyang Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Paul C. Lauterbur Research Center for Biomedical Imaging, CAS Key Laboratory of Health Informatics, Shenzhen Key Laboratory of Ultrasound Imaging and…. Hauptthemen laut MEDLINE: Coloring Agents, Neoplasms. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Fluorescence imaging in the second near‐infrared window (NIR‐II, 1000–1700 nm) provides a powerful tool for in vivo structural and functional imaging in deep tissue. However, the lack of biocompatible contrast agents with bright NIR‐II emission has hindered its application in fundamental research and clinical trials. Herein, a liposome encapsulation strategy for generating ultrabright liposome‐cyanine dyes by restricting dyes in the hydrophobic pockets of lipids and inhibiting the aggregation, as corroborated by computational modeling, is reported. Compared with free indocyanine green (ICG, an US Food and Drug Administration‐approved cyanine dye), liposome‐encapsulated ICG (S‐Lipo‐ICG) shows a 38.7‐fold increase in NIR‐II brightness and enables cerebrovascular imaging at only one‐tenth dose over a long period (30 min). By adjusting the excitation wavelength, two liposome‐encapsulated cyanine dyes (S‐Lipo‐ICG and S‐Lipo‐FD1080) enable NIR‐II dual‐color imaging. Moreover, small tumor nodules (2–5 mm) can be successfully distinguished and removed with S‐Lipo‐ICG image‐guided tumor surgery in rabbit models. This liposome encapsulation maintains the metabolic pathway of ICG, promising for clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Paul C. Lauterbur Research Center for Biomedical Imaging, CAS Key Laboratory of Health Informatics, Shenzhen Key Laboratory of Ultrasound Imaging and Therapy, Institute of Biomedical and Health Engineering, Shenzhen Ins…
- Department of Chemistry and Center for NanoMedicine, National University of Singapore, Singapore, 117543, Singapore.
- BayRay Innovation Center, Shenzhen Bay Laboratory, Shenzhen, 518055, P. R. China.
- Department of Materials Science and Engineering, Southern University of Science and Technology, Shenzhen, 518055, P. R. China.
ORCID-Profile: Zonghai Sheng
Förderung
- Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Gao, D., Luo, Z., He, Y., Yang, L., Hu, D., Liang, Y., Zheng, H., Liu, X., & Sheng, Z. (2023). Low‐Dose NIR‐II Preclinical Bioimaging Using Liposome‐Encapsulated Cyanine Dyes. Small. https://doi.org/10.1002/smll.202206544
Vancouver
Gao D, Luo Z, He Y, Yang L, Hu D, Liang Y, et al. Low‐Dose NIR‐II Preclinical Bioimaging Using Liposome‐Encapsulated Cyanine Dyes. Small. 2023. doi:10.1002/smll.202206544
BibTeX
@article{Gao2023,
author = {Gao, Duyang and Luo, Zichao and He, Yang and Yang, Lixiang and Hu, Dehong and Liang, Yongye and Zheng, Hairong and Liu, Xiaogang and Sheng, Zonghai},
title = {Low‐Dose NIR‐II Preclinical Bioimaging Using Liposome‐Encapsulated Cyanine Dyes},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202206544}
}
EUVIMED